Displaying 521 - 540 of 1925
Pfizer/Mylan, In the Matter of
Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. The FTC’s complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers, and that it would harm future U.S. competition in three additional product markets. The proposed consent order requires divestitures in all 10 markets.
FTC Again Charges Endo and Impax with Illegally Preventing Competition in U.S. Market for Oxymorphone ER
FTC Acting Chair Rebecca Kelly Slaughter Announces Interim Leadership Appointments
FTC Publishes Annual Performance Report
FTC Chairman Simons Announces his Resignation and the Departure of Senior Staff
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding the Commission’s Advocacy to the Department of Veterans Affairs
FTC Comment to Department of Veterans Affairs Supports Agency’s Interim Final Rule on VA Professionals’ Authority to Practice Health Care
Dissenting Statement of Commissioner Rohit Chopra Regarding the Commission's Advocacy to the Department of Veterans Affairs
FTC to Study the Impact of Physician Group and Healthcare Facility Mergers
FTC Publishes Inflation-Adjusted Civil Penalty Amounts for 2021
Statement of Ian Conner, Director of the FTC’s Bureau of Competition, Regarding the Announcement that The Procter & Gamble Company has Abandoned Its Proposed Acquisition of Billie, Inc.
CoStar Group / RentPath Holdings, In the Matter of
The Federal Trade Commission filed an administrative complaint and authorized a suit in federal court to block internet listing services provider CoStar Group Inc.’s proposed $587.5 million acquisition of competitor RentPath Holdings, Inc. The complaint alleged that the acquisition would significantly increase concentration in the already highly concentrated markets for internet listing services advertising for large apartment complexes in 49 individual metropolitan areas across the United States. On Dec. 31, 2020, the FTC issued a statement on the parties’ announcement that they had abandoned the acquisition.
Statement of Daniel Francis, Deputy Director of the FTC’s Bureau of Competition, Regarding the Announcement That the Parties Have Abandoned CoStar Group Inc.’s Acquisition of RentPath Holdings, Inc.
Methodist Le Bonheur Healthcare, In the Matter of
The Federal Trade Commission filed an administrative complaint, and authorized a suit in federal court, to block the proposed $350 million acquisition by Memphis-based Methodist Le Bonheur Healthcare of two Memphis-area hospitals, known as Saint Francis, owned by Dallas-based healthcare system Tenet Healthcare Corporation. The complaint alleges that the proposed acquisition would substantially lessen competition in the Memphis area for a broad range of inpatient medical and surgical diagnostic and treatment services that require an overnight hospital stay, known as inpatient general acute care services, sold to commercial insurers and their insured members. According to the complaint, if the proposed acquisition is consummated, healthcare costs will rise, and the incentive to expand service offerings, invest in technology, improve access to care, and focus on quality of health care provided in the Memphis area will diminish. On Dec. 23, 2020, the parties announced that they were abandoning the acquisition.
FTC Imposes Conditions on E. & J. Gallo Winery’s Acquisition of Assets from Constellation Brands, Inc.
Statement of Daniel Francis, Deputy Director of the FTC’s Bureau of Competition, Regarding the Announcement that Methodist Le Bonheur Healthcare has Abandoned Its Proposed Acquisition of Two Memphis-area Hospitals from Tenet Healthcare
Federal Trade Commission's Commentary on Vertical Merger Enforcement
Displaying 521 - 540 of 1925